Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT2M7YX)

DTT Name	EGFR Exon20ins mutant (EGFR Exon20ins) DTT Info
Gene Name	EGFR

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

1 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Mobocertinib	DMFWE9S	Non-small-cell lung cancer	2C25	Approved	[1]
------------------------------------------------------------------------------------

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
DZD9008	DM72DU3	Non-small-cell lung cancer	2C25	Phase 1/2	[2]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer. Cancer Discov. 2021 Feb 25;candisc.1683.2020.
2	Clinical pipeline report, company report or official report of Dizal Pharmaceuticals.